This announcement is a separate document:
瑞科生物-B：(1) 建議採納2022年H股激勵計劃 (2) 建議授權董事會及授權人士辦理2022年H股激勵計劃有關事宜 (3) 建議修訂公司章程 (4) 監事辭任及改選監事會主席及 (5) 暫停辦理股份過戶登記手續
RECBIO-B: (1) PROPOSED ADOPTION OF 2022 H SHARE INCENTIVE SCHEME (2) PROPOSED AUTHORIZATION GRANTED TO THE BOARD AND ITS DELEGATES TO DEAL WITH MATTERS RELATED TO THE 2022 H SHARE INCENTIVE SCHEME (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION (4)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.